<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The extracellular <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> fibrillin-1 forms microfibrils that act as the template for elastic fibers </plain></SENT>
<SENT sid="1" pm="."><plain>Most mutations in fibrillin-1 cause <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> with severe cardiovascular and ocular symptoms, and <z:hpo ids='HP_0000098'>tall stature</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This is in contrast to mutations within a <z:chebi fb="5" ids="28304">heparin</z:chebi>-binding TB domain (TB5), which is downstream of the arg-gly-asp cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> domain, which can cause <z:e sem="disease" ids="C0265313" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Weill-Marchesani syndrome</z:e> (WMS) or Acromicric (AD) and Geleophysic <z:mpath ids='MPATH_589'>Dysplasias</z:mpath> (GD) </plain></SENT>
<SENT sid="3" pm="."><plain>WMS is characterized by <z:mp ids='MP_0000547'>short limbs</z:mp>, <z:hpo ids='HP_0001387'>joint stiffness</z:hpo> and ocular defects, whilst fibrillin-1 AD and GD have <z:hpo ids='HP_0003510'>severe short stature</z:hpo>, joint defects and <z:hpo ids='HP_0001072'>thickened skin</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We previously showed that TB5 binds <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Here, we show that the corresponding region of fibrillin-2 binds <z:chebi fb="5" ids="28304">heparin</z:chebi> very poorly, highlighting a novel functional difference between the two isoforms </plain></SENT>
<SENT sid="6" pm="."><plain>This finding enabled us to map <z:chebi fb="5" ids="28304">heparin</z:chebi>/<z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> binding to two sites on fibrillin-1 TB5 using a mutagenesis approach </plain></SENT>
<SENT sid="7" pm="."><plain>Once these sites were mapped, we were able to investigate whether disease-causing mutations in this domain disrupt binding to HS </plain></SENT>
<SENT sid="8" pm="."><plain>We show that a WMS deletion mutant, and five AD and GD point mutants <z:hpo ids='HP_0000001'>all</z:hpo> have disrupted <z:chebi fb="5" ids="28304">heparin</z:chebi> binding to TB5 </plain></SENT>
<SENT sid="9" pm="."><plain>These data provide insights into the biology of fibrillins and the pathologies of WMS, AD and GD </plain></SENT>
</text></document>